Drugs / Mentor Purified Toxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00752258 | Feb 2008 → May 2011 | — | Mentor Worldwide, LLC | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT00752050 Comparator | Nov 2007 → Feb 2009 | — | Mentor Worldwide, LLC | Completed | No outcome recorded |
| Phase 3 | NCT00752297 Comparator | Jun 2007 → May 2008 | — | Mentor Worldwide, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mentor Purified Toxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00752258 ↗ |
| Route | Intramuscular | “five 0.1 mL intramuscular injections” NCT00752050 ↗ |